Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Austria

Product information
, 

Octreoscan™ in Belgium

Product information
, 

Octreoscan™ in Czech Republic

Product information
, 

Octreoscan™ in Denmark

Product information
, 

Octreoscan™ in France

Product information
, 

Octreoscan™ in Germany

Product information
, 

Octreoscan™ in Greece

Product information
, 

Octreoscan™ in Hungary

Product information
, 

Octreoscan™ in International

Product information
, 

Octreoscan™ in Ireland

Product information
, 

Octreoscan™ in Italy

Product information
, 

Octreoscan™ in Mexico

Product information
, 

Octreoscan™ in Netherlands

Product information
, 

Octreoscan™ in Portugal

Product information
, 

Octreoscan™ in Republic of Korea

Product information
, 

Octreoscan™ in Singapore

Product information
, 

Octreoscan™ in Slovakia

Product information
, 

Octreoscan™ in Spain

Product information
, 

Octreoscan™ in Sweden

Product information
, 

Octreoscan™ in United Kingdom

Product information

Octreoscan™ in United States

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Austria

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Belgium

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Bosnia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Colombia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Costa Rica

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Czech Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Denmark

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Dominican Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Finland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in France

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Germany

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Hungary

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Italy

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Mexico

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Netherlands

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Norway

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Peru

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Portugal

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Serbia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Slovakia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Spain

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Sweden

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Switzerland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Turkey

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Teceos®

Teceos 13 mg kit for radiopharmaceutical preparation

Active ingredient

Butedronate tetrasodium

Disease area

Cardiology, Oncology

Available in
, 

Teceos® in Austria

Product information
, 

Teceos® in Denmark

Product information
, 

Teceos® in Finland

Product information
, 

Teceos® in France

Product information
, 

Teceos® in Germany

Product information
, 

Teceos® in Greece

Product information
, 

Teceos® in International

Product information
, 

Teceos® in Mexico

Product information
, 

Teceos® in Netherlands

Product information
, 

Teceos® in Norway

Product information
, 

Teceos® in Republic of Korea

Product information
, 

Teceos® in Spain

Product information
, 

Teceos® in Sweden

Product information

Teceos® in Switzerland

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Austria

Product information
, 

Technescan™ MAG3 in Belgium

Product information
, 

Technescan™ MAG3 in Colombia

Product information
, 

Technescan™ MAG3 in Czech Republic

Product information
, 

Technescan™ MAG3 in Denmark

Product information
, 

Technescan™ MAG3 in Finland

Product information
, 

Technescan™ MAG3 in France

Product information
, 

Technescan™ MAG3 in Germany

Product information
, 

Technescan™ MAG3 in Greece

Product information
, 

Technescan™ MAG3 in Hungary

Product information
, 

Technescan™ MAG3 in Ireland

Product information
, 

Technescan™ MAG3 in Italy

Product information
, 

Technescan™ MAG3 in Malaysia

Product information
, 

Technescan™ MAG3 in Mexico

Product information
, 

Technescan™ MAG3 in Netherlands

Product information
, 

Technescan™ MAG3 in Norway

Product information
, 

Technescan™ MAG3 in Peru

Product information
, 

Technescan™ MAG3 in Portugal

Product information
, 

Technescan™ MAG3 in Republic of Korea

Product information
, 

Technescan™ MAG3 in Slovakia

Product information
, 

Technescan™ MAG3 in Spain

Product information
, 

Technescan™ MAG3 in Sweden

Product information
, 

Technescan™ MAG3 in Switzerland

Product information
, 

Technescan™ MAG3 in Turkey

Product information

Technescan™ MAG3 in United Kingdom

Product information

Technescan™ PYP

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Technescan™ PYP in Belgium

Product information
, 

Technescan™ PYP in Colombia

Product information
, 

Technescan™ PYP in Costa Rica

Product information
, 

Technescan™ PYP in Czech Republic

Product information
, 

Technescan™ PYP in Denmark

Product information
, 

Technescan™ PYP in Finland

Product information
, 

Technescan™ PYP in France

Product information
, 

Technescan™ PYP in Germany

Product information
, 

Technescan™ PYP in Hungary

Product information
, 

Technescan™ PYP in Ireland

Product information
, 

Technescan™ PYP in Italy

Product information
, 

Technescan™ PYP in Malaysia

Product information
, 

Technescan™ PYP in Mexico

Product information
, 

Technescan™ PYP in Netherlands

Product information
, 

Technescan™ PYP in Norway

Product information
, 

Technescan™ PYP in Peru

Product information
, 

Technescan™ PYP in Republic of Korea

Product information
, 

Technescan™ PYP in Romania

Product information
, 

Technescan™ PYP in Singapore

Product information
, 

Technescan™ PYP in Spain

Product information
, 

Technescan™ PYP in Sweden

Product information
, 

Technescan™ PYP in Turkey

Product information

Technescan™ PYP in United Kingdom

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information